Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...
Emerging from stealth, the company is debuting NEXUS, a Large Tabular Model (LTM) designed to treat business data not as a ...
Q4 2025 Earnings Call February 5, 2026 8:00 AM ESTCompany ParticipantsJean-Laurent Bonnafe - MD, CEO & DirectorLars Machenil ...
AZoLifeSciences on MSN
Overcoming endosomal escape in oligonucleotide drug delivery
This study addresses endosomal escape in oligonucleotide therapies and how engineered peptides can enhance intracellular drug delivery efficiency.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果